C - Chemistry – Metallurgy – 07 – C
Patent
C - Chemistry, Metallurgy
07
C
C07C 259/06 (2006.01) A61K 31/16 (2006.01) A61K 31/22 (2006.01) A61K 31/33 (2006.01) A61K 31/38 (2006.01) A61K 31/42 (2006.01) C07D 207/337 (2006.01) C07D 213/56 (2006.01) C07D 263/32 (2006.01) C07D 271/06 (2006.01) C07D 277/30 (2006.01) C07D 285/04 (2006.01) C07D 307/54 (2006.01) C07D 333/24 (2006.01)
Patent
CA 2158352
Compounds of formula (I), wherein R2 represents a C2- C6 alkyl group which may contain an ether or thioether linkage; R3 represents (a) the side chain of a naturally occurring alpha- amino acid in which any carboxylic acid group may be esterified or amidated, any hydroxyl or thiol group may be acylated or alkylated (etherified) and any amino group may be acylated, or (b) a group R6(A)n-, wherein n is 0 or 1, A represents a divalent C1-C6 alkyl or C2-C6 alkenyl group optionally interrupted by one or more -O-, or -S- atoms or -N(R7)- groups where R7 is hydrogen or C1-C6 alkyl, and R6 is a phenyl or heterocyclyl group either of which may be substituted, or (except where n is 0) a hydrogen atom; R4 represents hydrogen or methyl; R5 represents hydrogen, C1-C6 alkyl or phenyl(C1-C6 alkyl), and salts, solvates and hydrates thereof, are inhibitors of metalloproteinases involved in tissue degradation.
Beckett Raymond Paul
Crimmin Michael John
Davis Mark Hampton
British Biotech Pharmaceuticals Limited
Gowling Lafleur Henderson Llp
LandOfFree
Hydroxamic acid derivatives as metalloproteinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hydroxamic acid derivatives as metalloproteinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hydroxamic acid derivatives as metalloproteinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1616782